(New York, NY) – July 15, 2014 – AiCure, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, has been awarded its fifth patent titled “Method and Apparatus for Verification of Medication Administration Adherence” by the United States Patent and Trademark Office. US patent 8,781,856 issued on July 15, 2014 and protects AiCure’s medication adherence verification solution. This newly issued patent, as well as others in the AiCure portfolio, protects the unique method and system for providing interactive feedback to a patient in real time to assist in assuring proper medication administration.
AiCure has been pursuing an aggressive development and protection program for its critical intellectual property assets since 2009. With US and global patent applications already filed and issued, and additional technology in the process of being protected, these critically important assets are at the forefront for AiCure.